000			02199 a2200625 4500
005			20250514012012.0
264		0	_c20020123
008			200201s 0 0 eng d
022			_a0969-9961
024	7		_a10.1006/nbdi.2001.0422 _2doi
040			_aNLM _beng _cNLM
100	1		_aRefolo, L M
245	0	0	_aA cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. _h[electronic resource]
260			_bNeurobiology of disease _cOct 2001
300			_a890-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAlzheimer Disease _xblood
650	0	4	_aAmyloid Precursor Protein Secretases
650	0	4	_aAmyloid beta-Peptides _xanalysis
650	0	4	_aAmyloid beta-Protein Precursor _xanalysis
650	0	4	_aAnimals
650	0	4	_aAnticholesteremic Agents _xpharmacology
650	0	4	_aAspartic Acid Endopeptidases
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aCholesterol _xanalysis
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEndopeptidases _xmetabolism
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMembrane Proteins _xanalysis
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aNerve Tissue Proteins _xanalysis
650	0	4	_aOxidoreductases _xantagonists & inhibitors
650	0	4	_aOxidoreductases Acting on CH-CH Group Donors
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aPresenilin-1
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aSerum Amyloid P-Component _xanalysis
700	1		_aPappolla, M A
700	1		_aLaFrancois, J
700	1		_aMalester, B
700	1		_aSchmidt, S D
700	1		_aThomas-Bryant, T
700	1		_aTint, G S
700	1		_aWang, R
700	1		_aMercken, M
700	1		_aPetanceska, S S
700	1		_aDuff, K E
773	0		_tNeurobiology of disease _gvol. 8 _gno. 5 _gp. 890-9
856	4	0	_uhttps://doi.org/10.1006/nbdi.2001.0422 _zAvailable from publisher's website
999			_c11512982 _d11512982